Press Releases

An international research team led by the Research Center Borstel, developed a new method to label tubercle bacilli, the causative agents of tuberculosis with unique identifiers created from whole

New experiments conducted at the insectarium (high biosafety level 3) of the Bernhard Nocht Institute for Tropical Medicine (BNITM) and at the DZIF show that chikungunya viruses are able to replicate

On the eve of World Hepatitis Day, the International Coalition to Eliminate HBV (ICE-HBV) has called in the Comment of Nature Reviews Gastroenterology & Hepatology to support appropriate hepatitis B

This summer there will be a particularly large amount of ticks and thus a higher risk of getting meningitis or Lyme disease (borreliosis), because these diseases are transmitted by ticks. Scientists

The first antibiotic against tuberculosis that has been developed in Germany is now ready for clinical testing. BTZ043, as the newly developed drug substance is called, is also effective against

The German Federal Ministry of Education and Research is joining forces with international partners in a new initiative to promote research into antimicrobial resistance (AMR). The aim is to fight

The advisory board has appointed Professor Christoph Lange, Chief Physician of the Medical Clinic of the Research Center Borstel Hospital as the new Medical Director. Christoph Lange is Co-coordinator

Prof Rolf Müller was honoured with the Inhoffen Prize for his outstanding research in the field of microbial natural product discovery, particularly from Myxobacteria. Müller heads the Helmholtz

Early detection of antibiotic resistant pathogens can be life-saving. DZIF-scientists at the Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, have developed an

Human herpesvirus 6 infects most people all over the world. It is usually well controlled by the body, but it can cause diseases in immunocompromised individuals. As reported in ‘PLOS Pathogens’, DZIF